JNJ-42153605
≥98%
- Product Code: 101103
CAS:
1254977-87-1
| Molecular Weight: | 400.44 g./mol | Molecular Formula: | C₂₂H₂₃F₃N₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
JNJ-42153605 is primarily investigated for its potential therapeutic applications in the field of psychiatry and neurology. It acts as a positive allosteric modulator (PAM) of the metabotropic glutamate receptor 2 (mGluR2), which plays a significant role in modulating neurotransmitter release and synaptic plasticity. This mechanism makes it a promising candidate for the treatment of psychiatric disorders such as schizophrenia, where dysregulation of glutamate signaling is often implicated. By enhancing mGluR2 activity, JNJ-42153605 may help normalize glutamate levels, potentially alleviating symptoms like cognitive deficits, hallucinations, and mood disturbances. Additionally, its application is being explored in anxiety disorders and other conditions linked to glutamate dysfunction. The compound’s ability to target specific receptor subtypes with minimal side effects could offer a more refined approach compared to traditional antipsychotic medications.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.002 | 10-20 days | ฿12,312.00 |
+
-
|
| 0.005 | 10-20 days | ฿22,572.00 |
+
-
|
JNJ-42153605
JNJ-42153605 is primarily investigated for its potential therapeutic applications in the field of psychiatry and neurology. It acts as a positive allosteric modulator (PAM) of the metabotropic glutamate receptor 2 (mGluR2), which plays a significant role in modulating neurotransmitter release and synaptic plasticity. This mechanism makes it a promising candidate for the treatment of psychiatric disorders such as schizophrenia, where dysregulation of glutamate signaling is often implicated. By enhancing mGluR2 activity, JNJ-42153605 may help normalize glutamate levels, potentially alleviating symptoms like cognitive deficits, hallucinations, and mood disturbances. Additionally, its application is being explored in anxiety disorders and other conditions linked to glutamate dysfunction. The compound’s ability to target specific receptor subtypes with minimal side effects could offer a more refined approach compared to traditional antipsychotic medications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :